Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;34(3):e70123.
doi: 10.1002/pds.70123.

Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data

Joshua U Okonkwo  1   2 , Erika K Williams  1   2 , Reza Sadjadi  1   2 , Sebastian Schneeweiss  2   3   4 , Colin Anderson-Smits  5 , Hakan Ay  5 , William Spalding  5 , Priyanka Anand  3 , Zhigang Lu  3 , Kueiyu Joshua Lin  2   3   4
Affiliations

Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data

Joshua U Okonkwo et al. Pharmacoepidemiol Drug Saf. 2025 Mar.

Abstract

Purpose: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune condition of the peripheral nervous system. The validity of the CIDP diagnosis code in claims data is unclear.

Methods: We conducted a validation study testing the performance of claims-based algorithms in identifying CIDP cases, using electronic health record data from the Mass General Brigham Integrated Health Care System linked with Medicare claims data from 01/01/2008 to 12/31/2020. The algorithms require a record of intravenous immunoglobulin (IVIG) use and International Classification of Diseases 9th/10th Revision (ICD9/10) CIDP codes before (including) the date of IVIG use. The positive predictive values (PPVs) of each claims-based algorithm were calculated against the reference standard for CIDP and chronic immune-mediated acquired neuropathy established through chart review by two board-certified neurologists using a standardized abstraction tool.

Results: The study cohort consisted of 140 patients (59 in the ICD9 and 81 in the ICD10 era). The PPV of the algorithm requiring at least one CIDP diagnosis code before IVIG use was 66.2% (95% confidence interval [CI], 58.0-74.3). The PPV improved to 71.2% (62.7-79.6) when requiring at least two CIDP codes before IVIG use. The PPV for patients with at least one CIDP code who met the European Academy of Neurology/Peripheral Nerve Society 2021 diagnostic criteria was 30.0% (22.1-37.9).

Conclusion: We found that a patient cohort identified using claims-based CIDP diagnoses included a substantial number of patients with other chronic inflammatory acquired neuropathies not formally recognized as CIDP by clinical consensus criteria. Requiring two CIDP codes can improve PPVs.

Keywords: chronic immune‐mediated acquired neuropathy; chronic inflammatory demyelinating polyradiculoneuropathy; claims‐based algorithm validation; intravenous immunoglobulin.

PubMed Disclaimer

References

    1. M. C. Broers, C. Bunschoten, D. Nieboer, H. F. Lingsma, and B. C. Jacobs, “Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta‐Analysis,” Neuroepidemiology 52, no. 3–4 (2019): 161–172, https://doi.org/10.1159/000494291.
    1. R. J. Desai, K. J. Lin, E. Patorno, et al., “Development and Preliminary Validation of a Medicare Claims‐Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure,” Circulation. Cardiovascular Quality and Outcomes 11, no. 12 (2018): e004700, https://doi.org/10.1161/CIRCOUTCOMES.118.004700.
    1. K. J. Lin, D. E. Singer, R. J. Glynn, S. N. Murphy, J. Lii, and S. Schneeweiss, “Identifying Patients With High Data Completeness to Improve Validity of Comparative Effectiveness Research in Electronic Health Records Data,” Clinical Pharmacology & Therapeutics 103, no. 5 (2018): 899–905, https://doi.org/10.1002/cpt.861.
    1. K. J. Lin, R. J. Glynn, D. E. Singer, S. N. Murphy, J. Lii, and S. Schneeweiss, “Out‐of‐System Care and Recording of Patient Characteristics Critical for Comparative Effectiveness Research,” Epidemiology 29, no. 3 (2018): 356–363, https://doi.org/10.1097/EDE.0000000000000794.
    1. P. Y. K. Van den Bergh, P. A. van Doorn, R. D. M. Hadden, et al., “European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force‐Second Revision,” Journal of the Peripheral Nervous System 26, no. 3 (2021): 242–268, https://doi.org/10.1111/jns.12455.

Publication types

MeSH terms

Substances

LinkOut - more resources